EMEA (Europe, Middle East and Africa) Nonalcoholic Steatohepatitis (NASH) Market Report 2018

March 2018 | 110 pages | ID: E80CFA6CA53QEN
QYResearch

Abstracts

In this report, the EMEA Nonalcoholic Steatohepatitis (NASH) market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Nonalcoholic Steatohepatitis (NASH) for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nonalcoholic Steatohepatitis (NASH) market competition by top manufacturers/players, with Nonalcoholic Steatohepatitis (NASH) sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Boehringer Ingelheim
• Cerenis Therapeutics
• Connexios Life Sciences
• Genfit
• Islet Sciences
• Nimbus Therapeutics
• Verva Pharmaceuticals
• Viking Therapeutics
• Astazeneca Plc
• Galmed Pharmaceuticals
• GENFIT SA
• Gilead Science
• Novo Nordisk
• Immuron
• Intercepts Pharmaceuticals
• Enzo Biochem
• Tobira Therapeutics

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Weight Loss Treatment
• Insulin-Sensitizing Agents
• Lipid-Lowering Drugs
• Antioxidants
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Research Institute
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nonalcoholic Steatohepatitis (NASH) Market Report 2018

1 NONALCOHOLIC STEATOHEPATITIS (NASH) OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Classification of Nonalcoholic Steatohepatitis (NASH)
  1.2.1 EMEA Nonalcoholic Steatohepatitis (NASH) Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Nonalcoholic Steatohepatitis (NASH) Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Weight Loss Treatment
  1.2.4 Insulin-Sensitizing Agents
  1.2.5 Lipid-Lowering Drugs
  1.2.6 Antioxidants
  1.2.7 Other
1.3 EMEA Nonalcoholic Steatohepatitis (NASH) Market by Application/End Users
  1.3.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Research Institute
  1.3.5 Other
1.4 EMEA Nonalcoholic Steatohepatitis (NASH) Market by Region
  1.4.1 EMEA Nonalcoholic Steatohepatitis (NASH) Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Nonalcoholic Steatohepatitis (NASH) (2013-2025)
  1.5.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2025)

2 EMEA NONALCOHOLIC STEATOHEPATITIS (NASH) COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nonalcoholic Steatohepatitis (NASH) Market Competition by Players/Manufacturers
  2.1.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Nonalcoholic Steatohepatitis (NASH) Sale Price by Players (2013-2018)
2.2 EMEA Nonalcoholic Steatohepatitis (NASH) (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Nonalcoholic Steatohepatitis (NASH) Sale Price by Type (2013-2018)
2.3 EMEA Nonalcoholic Steatohepatitis (NASH) (Volume) by Application
2.4 EMEA Nonalcoholic Steatohepatitis (NASH) (Volume and Value) by Region
  2.4.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Nonalcoholic Steatohepatitis (NASH) Sales Price by Region (2013-2018)

3 EUROPE NONALCOHOLIC STEATOHEPATITIS (NASH) (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
  3.1.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
3.2 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
3.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application
3.4 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales Volume by Countries (2013-2018)
  3.4.2 Europe Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)
  3.4.3 Germany Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  3.4.4 France Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  3.4.5 UK Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  3.4.6 Russia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  3.4.7 Italy Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)

4 MIDDLE EAST NONALCOHOLIC STEATOHEPATITIS (NASH) (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
  4.1.1 Middle East Nonalcoholic Steatohepatitis (NASH) Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
4.2 Middle East Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
4.3 Middle East Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application
4.4 Middle East Nonalcoholic Steatohepatitis (NASH) Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nonalcoholic Steatohepatitis (NASH) Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  4.4.4 Israel Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  4.4.5 UAE Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  4.4.6 Iran Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)

5 AFRICA NONALCOHOLIC STEATOHEPATITIS (NASH) (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nonalcoholic Steatohepatitis (NASH) Sales and Value (2013-2018)
  5.1.1 Africa Nonalcoholic Steatohepatitis (NASH) Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
5.2 Africa Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Type
5.3 Africa Nonalcoholic Steatohepatitis (NASH) Sales and Market Share by Application
5.4 Africa Nonalcoholic Steatohepatitis (NASH) Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nonalcoholic Steatohepatitis (NASH) Sales Volume by Countries (2013-2018)
  5.4.2 Africa Nonalcoholic Steatohepatitis (NASH) Revenue by Countries (2013-2018)
  5.4.3 South Africa Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2013-2018)

6 EMEA NONALCOHOLIC STEATOHEPATITIS (NASH) MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Cerenis Therapeutics
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Connexios Life Sciences
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Genfit
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Genfit Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Islet Sciences
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Nimbus Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Verva Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Viking Therapeutics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Astazeneca Plc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Galmed Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Nonalcoholic Steatohepatitis (NASH) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 GENFIT SA
6.12 Gilead Science
6.13 Novo Nordisk
6.14 Immuron
6.15 Intercepts Pharmaceuticals
6.16 Enzo Biochem
6.17 Tobira Therapeutics

7 NONALCOHOLIC STEATOHEPATITIS (NASH) MANUFACTURING COST ANALYSIS

7.1 Nonalcoholic Steatohepatitis (NASH) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST (2018-2025)

11.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Nonalcoholic Steatohepatitis (NASH) Price and Trend Forecast (2018-2025)
11.2 EMEA Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type (2018-2025)
11.7 EMEA Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nonalcoholic Steatohepatitis (NASH)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Type (Product Category) in 2017
Figure Weight Loss Treatment Product Picture
Figure Insulin-Sensitizing Agents Product Picture
Figure Lipid-Lowering Drugs Product Picture
Figure Antioxidants Product Picture
Figure Other Product Picture
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Research Institute Examples
Table Key Downstream Customer in Research Institute
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Market Size (Million USD) by Region (2013-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Volume and Growth Rate (2013-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales Share by Players (2013-2018)
Figure 2017 Nonalcoholic Steatohepatitis (NASH) Sales Share by Players
Figure 2017 Nonalcoholic Steatohepatitis (NASH) Sales Share by Players
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Players (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players (2013-2018)
Table 2017 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players
Table 2017 EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Share by Players
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales Share by Type (2013-2018)
Figure Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2013-2018)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2017
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales Share by Application (2013-2018)
Figure Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Application (2013-2018)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2017
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales Share by Region (2013-2018)
Figure Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Region (2013-2018)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Market Share in 2017
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Nonalcoholic Steatohepatitis (NASH) by Region (2013-2018)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Regions in 2017
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Type (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type in 2017
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Application (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application in 2017
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Countries (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Countries (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Countries (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Countries in 2017
Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)
Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017
Figure Germany Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Type (2013-2018)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2013-2018)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Applications (2013-2018)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Market Share by Applications (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2017
Table Middle East Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Sales Volume Market Share by Countries in 2017
Table Middle East Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Type (2013-2018)
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type in 2017
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) by Application (2013-2018)
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2013-2018)
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Countries (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Countries (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Countries in 2017
Table Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) by Countries (2013-2018)
Table Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries (2013-2018)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Countries in 2017
Figure South Africa Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Table Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Boehringer Ingelheim Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Cerenis Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Connexios Life Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Genfit Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Genfit Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Genfit Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Islet Sciences Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Islet Sciences Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Nimbus Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Verva Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Viking Therapeutics Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Astazeneca Plc Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales Market Share in EMEA (2013-2018)
Figure Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Revenue Market Share in EMEA (2013-2018)
Table GENFIT SA Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Gilead Science Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Immuron Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Intercepts Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Enzo Biochem Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Steatohepatitis (NASH)
Figure Manufacturing Process Analysis of Nonalcoholic Steatohepatitis (NASH)
Figure Nonalcoholic Steatohepatitis (NASH) Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Steatohepatitis (NASH) Major Manufacturers in 2017
Table Major Buyers of Nonalcoholic Steatohepatitis (NASH)
Table Distributors/Traders List
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Region (2018-2025)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Region (2018-2025)
Table Europe Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Countries (2018-2025)
Table Europe Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Countries (2018-2025)
Table Africa Nonalcoholic Steatohepatitis (NASH) Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Nonalcoholic Steatohepatitis (NASH) Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Type (2018-2025)
Table EMEA Nonalcoholic Steatohepatitis (NASH) Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources